These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 12116045)

  • 21. Hepatitis B viral factors and clinical outcomes of chronic hepatitis B.
    Lin CL; Kao JH
    J Biomed Sci; 2008 Mar; 15(2):137-45. PubMed ID: 18058038
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficient inhibition of hepatitis B virus replication by small interfering RNAs targeted to the viral X gene in mice.
    Shin D; Kim SI; Kim M; Park M
    Virus Res; 2006 Aug; 119(2):146-53. PubMed ID: 16443303
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis B virus (HBV) genotypes/subgenotypes in China: mutations in core promoter and precore/core and their clinical implications.
    Yuan J; Zhou B; Tanaka Y; Kurbanov F; Orito E; Gong Z; Xu L; Lu J; Jiang X; Lai W; Mizokami M
    J Clin Virol; 2007 Jun; 39(2):87-93. PubMed ID: 17451999
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sustained and focused hepatitis B virus nucleocapsid-specific T-cell immunity in liver transplant recipients compared to individuals with chronic and self-limited hepatitis B virus infection.
    Bihl F; Loggi E; Chisholm JV; Biselli M; Morelli MC; Cursaro C; Terrault NA; Bernardi M; Bertoletti A; Andreone P; Brander C
    Liver Transpl; 2008 Apr; 14(4):478-85. PubMed ID: 18324666
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immune control of hepatitis B virus.
    Bauer T; Sprinzl M; Protzer U
    Dig Dis; 2011; 29(4):423-33. PubMed ID: 21894014
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Occult hepatitis B virus infection.
    Raimondo G; Pollicino T; Cacciola I; Squadrito G
    J Hepatol; 2007 Jan; 46(1):160-70. PubMed ID: 17112622
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Titration of hepatitis B virus infectivity in the sera of pre-acute and late acute phases of HBV infection: transmission experiments to chimeric mice with human liver repopulated hepatocytes.
    Tabuchi A; Tanaka J; Katayama K; Mizui M; Matsukura H; Yugi H; Shimada T; Miyakawa Y; Yoshizawa H
    J Med Virol; 2008 Dec; 80(12):2064-8. PubMed ID: 19040280
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of hepatitis B virus genotype mixture, subgenotypes C2 and B2 on hepatocellular carcinoma: compared with chronic hepatitis B and asymptomatic carrier state in the same area.
    Yin J; Zhang H; Li C; Gao C; He Y; Zhai Y; Zhang P; Xu L; Tan X; Chen J; Cheng S; Schaefer S; Cao G
    Carcinogenesis; 2008 Sep; 29(9):1685-91. PubMed ID: 18192693
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New insights into how HBV manipulates the innate immune response to establish acute and persistent infection.
    Revill P; Yuan Z
    Antivir Ther; 2013; 18(1):1-15. PubMed ID: 23363957
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The hepatitis B virus and common mutants.
    Locarnini S; McMillan J; Bartholomeusz A
    Semin Liver Dis; 2003 Feb; 23(1):5-20. PubMed ID: 12616447
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.
    Adachi S; Shibuya A; Miura Y; Takeuchi A; Nakazawa T; Saigenji K
    Scand J Gastroenterol; 2008; 43(7):849-56. PubMed ID: 18584524
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HBV and liver cancer.
    Leung N
    Med J Malaysia; 2005 Jul; 60 Suppl B():63-6. PubMed ID: 16108176
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biological features of hepatitis B virus isolates from patients based on full-length genomic analysis.
    Wen YM; Wang YX
    Rev Med Virol; 2009 Jan; 19(1):57-64. PubMed ID: 19058172
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathogenesis of hepatitis B virus infection.
    Baumert TF; Thimme R; von Weizsäcker F
    World J Gastroenterol; 2007 Jan; 13(1):82-90. PubMed ID: 17206757
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HBV DNA integration and HBV-transcript expression in non-B, non-C hepatocellular carcinoma in Japan.
    Tamori A; Nishiguchi S; Kubo S; Narimatsu T; Habu D; Takeda T; Hirohashi K; Shiomi S
    J Med Virol; 2003 Dec; 71(4):492-8. PubMed ID: 14556260
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytokines in viral hepatitis.
    Koziel MJ
    Semin Liver Dis; 1999; 19(2):157-69. PubMed ID: 10422198
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sustained survival of human hepatocytes in mice: A model for in vivo infection with human hepatitis B and hepatitis delta viruses.
    Ohashi K; Marion PL; Nakai H; Meuse L; Cullen JM; Bordier BB; Schwall R; Greenberg HB; Glenn JS; Kay MA
    Nat Med; 2000 Mar; 6(3):327-31. PubMed ID: 10700236
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunopathogenesis: role of innate and adaptive immune responses.
    Visvanathan K; Lewin SR
    Semin Liver Dis; 2006 May; 26(2):104-15. PubMed ID: 16673289
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Co-infection of human parvovirus B19 in Vietnamese patients with hepatitis B virus infection.
    Toan NL; Song le H; Kremsner PG; Duy DN; Binh VQ; Duechting A; Kaiser H; Torresi J; Kandolf R; Bock CT
    J Hepatol; 2006 Sep; 45(3):361-9. PubMed ID: 16684578
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis B virus infection: current status.
    Ocama P; Opio CK; Lee WM
    Am J Med; 2005 Dec; 118(12):1413. PubMed ID: 16378788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.